Catalytic antibodies in the bone marrow and other organs of Th mice during spontaneous development of experimental autoimmune encephalomyelitis associated with cell differentiation

[1]  S. Meuth,et al.  Changes in cell differentiation and proliferation lead to production of abzymes in EAE mice treated with DNA–Histone complexes , 2018, Journal of cellular and molecular medicine.

[2]  S. Meuth,et al.  Changes in Several Disease Parameters Including Abzymes and Hematopoietic Progenitor Colony Formation in Brain Inflammation and Demyelination , 2017 .

[3]  S. Meuth,et al.  Changes in haematopoietic progenitor colony differentiation and proliferation and the production of different abzymes in EAE mice treated with DNA , 2017, Journal of cellular and molecular medicine.

[4]  G. Nevinsky Catalytic Antibodies in Norm and Systemic Lupus Erythematosus , 2017 .

[5]  H. Wiendl,et al.  B7-H1 shapes T-cell–mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity , 2016, Proceedings of the National Academy of Sciences.

[6]  G. Nevinsky Autoimmune Processes in Multiple Sclerosis: Production of Harmful Catalytic Antibodies Associated with Significant Changes in the Hematopoietic Stem Cell Differentiation and Proliferation , 2016 .

[7]  E. Granieri,et al.  Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis , 2016, PloS one.

[8]  S. Meuth,et al.  Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein , 2015, Journal of cellular and molecular medicine.

[9]  E. Granieri,et al.  Comparison of Antibodies Hydrolyzing Myelin Basic Protein from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis , 2014, PloS one.

[10]  E. Granieri,et al.  Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis , 2014, PloS one.

[11]  V. Buneva,et al.  IgGs containing light chains of the λ- and κ- type and of all subclasses (IgG1-IgG4) from the sera of patients with systemic lupus erythematosus hydrolyze myelin basic protein. , 2012, International immunology.

[12]  G. Nevinsky Natural Catalytic Antibodies in Norm and in HIV-Infected Patients , 2011 .

[13]  F. Kasenga Understanding HIV/AIDS Management and Care - Pandemic Approaches in the 21st Century , 2011 .

[14]  V. Buneva,et al.  Affinity and catalytic heterogeneity and metal‐dependence of polyclonal myelin basic protein‐hydrolyzing IgGs from sera of patients with systemic lupus erythematosus , 2011, Journal of molecular recognition : JMR.

[15]  A. Waisman,et al.  Mouse models for multiple sclerosis: historical facts and future implications. , 2011, Biochimica et biophysica acta.

[16]  V. Buneva,et al.  Nucleotide-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice. , 2009, International immunology.

[17]  G. Nevinsky,et al.  Formation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoietic progenitors , 2007, Journal of cellular and molecular medicine.

[18]  V. Buneva,et al.  Antibodies with amylase activity from the sera of autoimmune‐prone MRL/MpJ‐lpr mice , 2006, FEBS letters.

[19]  O. Favorova,et al.  Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis. , 2006, Immunology letters.

[20]  O. Favorova,et al.  Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[21]  V. Buneva,et al.  Natural Catalytic Antibodies – Abzymes , 2005 .

[22]  O. Favorova,et al.  Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis , 2004, Journal of cellular and molecular medicine.

[23]  V. Buneva,et al.  Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases , 2003, Journal of cellular and molecular medicine.

[24]  V. A. Naumov,et al.  Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus. , 2002, Immunology letters.

[25]  H. Hartung,et al.  New concepts in the immunopathogenesis of multiple sclerosis , 2002, Nature Reviews Neuroscience.

[26]  O. Favorova,et al.  Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. , 2001, Immunology letters.

[27]  A. Bar-Or,et al.  The Neuroimmunology of Multiple Sclerosis: Possible Roles of T and B Lymphocytes in Immunopathogenesis , 2001, Journal of Clinical Immunology.

[28]  D. Burton,et al.  Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Cross,et al.  B cells and antibodies in CNS demyelinating disease , 2001, Journal of Neuroimmunology.

[30]  H. Hartung,et al.  Patients with active relapsing‐remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: Implications for remyelination , 2000, Annals of neurology.

[31]  H. Hartung,et al.  The role of B cells and autoantibodies in multiple sclerosis , 2000, Annals of neurology.

[32]  V. A. Naumov,et al.  Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. , 1998, Biochemistry. Biokhimiia.

[33]  I. Astsaturov,et al.  Novel functional activities of anti-dna autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases , 1998, Applied biochemistry and biotechnology.

[34]  Takato O. Yoshida,et al.  Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Caputo,et al.  Neuroimmunology in multiple sclerosis , 1983, The Italian Journal of Neurological Sciences.

[36]  Kim D. Janda,et al.  Catalytic antibodies , 2007, Cell Biochemistry and Biophysics.

[37]  S. Miller,et al.  Experimental Autoimmune Encephalomyelitis in the Mouse , 2007 .

[38]  H. Sinohara,et al.  Does catalytic activity of bence-jones proteins contribute to the pathogenesis of multiple myeloma? , 2000, Applied biochemistry and biotechnology.

[39]  O. Favorova,et al.  [Multiple sclerosis: molecular and cellular mechanisms]. , 1995, Molekuliarnaia biologiia.